Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus-Reference-Cited by-同舟云学术

Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus

Published:2004-10 Issue:5 Volume:24 Page:413-418
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Marinho Rui T.,Pinto Ruth M.,Santos Maria L.,de Moura Miguel Carneiro

Publisher

Wiley

Subject

Hepatology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2004.0947.x/fullpdf

Reference43 articles.

1. The Scientific Challenge of Hepatitis C

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

3. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

4. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C

5. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant hepatitis C serological testing in Australia and the implications for organ transplant programs;Journal of Clinical Virology;2013-05

2. Hepatitis C, stigma and cure;World Journal of Gastroenterology;2013

3. Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: A prospective study;Journal of Gastroenterology and Hepatology;2012-05-24

4. A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment;Journal of Viral Hepatitis;2011-04-24

5. A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide;Clinical Rheumatology;2010-10-06